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Objectives The study was designed to assess the ability of computer-simulated electrocardiography parameters to predict
clinical outcomes and to risk-stratify patients with long QT syndrome type 1 (LQT1).
Background Although attempts have been made to correlate mutation-specific ion channel dysfunction with patient pheno-
type in long QT syndrome, these have been largely unsuccessful. Systems-level computational models can be
used to predict consequences of complex changes in channel function to the overall heart rhythm.
Methods A total of 633 LQT1-genotyped subjects with 34 mutations from multinational long QT syndrome registries were
studied. Cellular electrophysiology function was determined for the mutations and introduced in a 1-dimensional
transmural electrocardiography computer model. The mutation effect on transmural repolarization was deter-
mined for each mutation and related to the risk for cardiac events (syncope, aborted cardiac arrest, and sudden
cardiac death) among patients.
Results Multivariate analysis showed that mutation-specific transmural repolarization prolongation (TRP) was associated
with an increased risk for cardiac events (35% per 10-ms increment [p  0.0001]; upper quartile hazard ratio:
2.80 [p  0.0001]) and life-threatening events (aborted cardiac arrest/sudden cardiac death: 27% per 10-ms
increment [p  0.03]; upper quartile hazard ratio: 2.24 [p  0.002]) independently of patients’ individual QT
interval corrected for heart rate (QTc). Subgroup analysis showed that among patients with mild to moder-
ate QTc duration (500 ms), the risk associated with TRP was maintained (36% per 10 ms [p  0.0001]),
whereas the patient’s individual QTc was not associated with a significant risk increase after adjustment
for TRP.
Conclusions These findings suggest that simulated repolarization can be used to predict clinical outcomes and to improve
risk stratification in patients with LQT1, with a more pronounced effect among patients with a lower-range QTc,
in whom a patient’s individual QTc may provide less incremental prognostic information. (J Am Coll Cardiol
2012;60:2182–91) © 2012 by the American College of Cardiology Foundation
Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.07.053Long QT syndrome (LQTS) may cause torsade de pointes
arrhythmia, ventricular fibrillation, and sudden cardiac
death (SCD). The disease can either be inherited as a
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November 20/27, 2012:2182–91 In Silico Risk Assessment LQTcaused by loss-of-function mutations in the KCNQ1 gene,
which encodes the alpha subunit of the cardiac ion channel
See page 2192
involved in the slow delayed rectifier potassium current (IKs)
(1). To date,300 different mutations have been identified in
his gene (2).
The occurrence of cardiac events in patients with LQT1
s variable, with proper risk stratification needed to optimize
atient treatment (3–6). Several phenotype variables have
een associated with a more severe clinical course in patients
ith LQT1. QT interval corrected for heart rate (QTc) is
ne of the most effective risk stratifiers in LQTS, with
revious studies showing a 4.2-fold risk increase in aborted
ardiac arrest (ACA) or SCD among patients with a QTc
500 ms (4). However, QTc can vary temporally and
mong individuals with the same mutation (7). Mutation
haracteristics have recently been shown to determine car-
iac risk in patients with genetically confirmed LQTS but
ormal-range QTc intervals (8–10). This suggests a strong
enetic component to cardiac risk that is not currently
nderstood.
Although several attempts have been made to correlate
ecrease in IKs function associated with specific mutations
ith patient phenotype, these attempts have been largely
nsuccessful (8,11–13). Systems level computational models
re highly developed in the field of cardiac physiology and
an be used to predict consequences of complex changes in
hannel function to the overall heart rhythm. The authors
ypothesized that: 1) mutation-specific transmural repolar-
zation prolongation (TRP), obtained by simulating trans-
ural electrocardiograms (ECGs) using a 1-dimensional
1D) cable model, will be an independent predictor of
ardiac events among patients with LQT1; and 2) data
egarding mutation-specific simulated TRP will identify
ncreased risk for cardiac events among patients with LQT1
ith mild to moderate QTc prolongation, in whom a
atient’s individual QTc provides less incremental prognos-
ic information.
ethods
imulation of pseudo-transmural ECGs with a 1D cable
odel. The 1D cable model of 192 cells was constructed
nd parameterized to represent the transmural heterogeneity
cross the ventricular wall. As shown in Figure 1A, each of
he 192 cells was assigned varying properties based on its
osition within the ventricular wall. The cell model was
dapted from the Flaim-Giles-McCulloch (FGM) recon-
truction of the canine cardiac cell (14). The FGM model
econstructs 3 stereotyped cell types: epicardial (Epi), endo-
ardial (Endo), and midmyocardial (M) cell responses. The
GM epicardial cell corresponds to the rightmost 30% of
he wall in the cable model (70% to 100% wall distance in
nline Fig. 1). The FGM endocardial cells correspond tohe leftmost edge of the cable
0%), while the midmyocardial
ell is mapped 10% wall depth in
he subendocardium. For the
resent model, the profiles of
onductance of late sodium cur-
ent (INaL) and IKs were linearly
interpolated between the differ-
ent stereotyped cell types (Online
Fig. 1). The model conduction
velocity and action potential du-
ration distributions are similar to
experimental data (Online Fig. 2).
The pseudo-transmural ECG
was computed based on the
transmural voltage gradient from
the epicardial to the endocardial
sides of the heart. In contrast to
models in some published studies
that report only a single electrode
voltage located near the epicar-
dium (15,16), the present model
generates T waves sensitive to
the whole transmural repolarization profile.
Wild type (WT) IKs current parameters in the model
were modified to mimic human IKs currents and currents
measured for channels containing LQT1 mutant subunits
previously reported by Jons et al (8). The first 5 cells are
stimulated with applied current, and the action potential
(AP) propagates to the end of the array. The AP propagates
along an array of 288 cells, with the central 192 cells used in
the analysis to circumvent edge artifacts (Online Fig. 3).
The pacing protocol consists of 60 beats at a 1000-ms
interval to bring the model to steady state. During the
simulation studies, the modeling team was blinded to as
which mutant corresponded to a given simulation (i.e., the
modified parameters for the mutation were provided with-
out a cross-reference to the mutation). For additional details
on the in silico methods, see Online Appendix.
Study population data collection and clinical endpoints.
The study population comprised 633 subjects derived from
103 LQT1 proband–identified families with genetically
confirmed KCNQ1 mutations for which mutant channel
properties are known, permitting simulation with the
method described here (see Online Table 1 for details of
mutations included [8]). Patients were drawn from 3 LQTS
registries—the U.S. part of the Rochester-based LQTS
Registry (n  488), the Japan-based LQTS Registry (n 
56), and the Netherlands-based LQTS Registry (n 
23)—as well as from data submitted by other investigators
specifically for this collaborative mutation-analysis project
(Denmark [n  12] and Sweden [n  4]). The proband in
each family had diagnostic QTc prolongation and may or
may not have experienced LQTS-related symptoms. Pa-
tients were excluded from the study if they had 1
Abbreviations
and Acronyms
ACA  aborted cardiac
arrest
AP  action potential
ECG  electrocardiography
FGM  Flaim-Giles-
McCulloch
IKs  rectifier potassium
current
LQT1  long QT syndrome
type 1
LQTS  long QT syndrome
Q4  upper quartile
QTc  QT interval
corrected by heart rate
SCD  sudden cardiac
death
TRP  transmural
repolarization prolongation
WT  wild-typeLQTS-causing mutation (n  9).
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In Silico Risk Assessment LQT November 20/27, 2012:2182–91Figure 1 Determination of TRP for Ion Channels Associated With LQT1
(A) The 192-cell array used in the computational simulation of transmural repolarization prolongation (TRP) in patients with long QT syndrome type 1 (LQT1). Action
potential determination for wild-type channels at the different cell types is shown. (B) Determination of pseudo-transmural electrocardiography (ECG) based on the wild-
type channel action potential duration across the array of cells. (C) Pseudo-transmural ECG simulated for mutant channels in the study with lower (left) and higher
(right) prolongation observed. A unique TRP parameter was determined for each mutant ion channel as indicated. (D) Correlation of TRP determined from simulation
with patient QT interval corrected for heart rate (QTc) for all patients genotype positive for each mutation. (E) Location of mutations in the study. Mutations associated
with the top quartile TRP are marked in red. Circle size indicates number of patients with the mutation.
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November 20/27, 2012:2182–91 In Silico Risk Assessment LQTUpon enrollment in the registry, clinical history was
obtained; thus follow-up data in the current study com-
prised historical data from birth to enrollment and prospec-
tive information collected at yearly intervals after enroll-
ment. The mean age at enrollment in the registry among the
patients from the Rochester registry (77% of the patients
studied) was 26 years, and follow-up for the survival analysis
was from birth through age 40 years. On average, 69% of
the follow-up data were obtained retrospectively at enroll-
ment. Only patients for whom a complete medical history
and prospective information were available were included in
the present study. Clinical history data were collected on
forms and included demographic characteristics, personal
and family medical history, ECG findings, medical thera-
pies, left cardiac sympathetic denervation, implantation of a
pacemaker or an implantable cardioverter defibrillator
(ICD), and the occurrence of LQTS-related cardiac events.
LQTS-related cardiac events included syncope, defined as
transient loss of consciousness abrupt in onset and offset,
ACA requiring defibrillation, and SCD without a known
cause. Each subject had a single individual QTc value
assigned, obtained at the time of entry in the LQT registry.
Genotyping. The KCNQ1 mutations were identified with
he use genetic tests performed in academic molecular-
enetic laboratories, including the Functional Genomics
enter, University of Rochester Medical Center, Rochester,
ew York; Baylor College of Medicine, Houston, Texas;
ayo Clinic College of Medicine, Rochester, Minnesota;
oston Children’s Hospital, Boston, Massachusetts; Labo-
atory of Molecular Genetics, National Cardiovascular Cen-
er, Suita, Japan; Department of Clinical Genetics, Aca-
emic Medical Center, Amsterdam, The Netherlands; and
tatens Serum Institut, Copenhagen, Denmark. For the
roband in each family, the 5 most common LQT loci
KCNQ1, KCNH2, SCN5A, KCNE1, and KCNE2) were
fully sequenced to identify the mutation by comparing the
sequence with those of healthy individuals without LQTS.
Once a mutation was identified in other family members,
and the KCNQ1 gene was sequenced to confirm the
presence or absence of the mutation.
Specifically, after informed consent was obtained, blood
samples from patients were sent for detailed mutational
analysis involving either 12 LQTS genes (KCNQ1,
KCNH2, SCN5A, ANK2, KCNE1, KCNE2, CACNA1C,
KCNJ2, CAV3, SCN4B, AKAP9, and SNTA1) or 5 LQTS
genes (KCNQ1, KCNH2, SCN5A, KCNE1, and KCNE2)
nd were screened for multiple LQTS mutations/
olymorphisms. Genetic tests included next-generation
NA sequencing of all of the coding exons. For that,
xons and adjacent splice sites of each of the genes were
equenced using a solid-state sequencing-by-synthesis
rocess (Illumina, Inc., San Diego, California). There are
ver 230 exons to be sequenced in LQTS; 12 gene panels
nd both alleles of each exon (maternal and paternal) were
equenced simultaneously. Polymerase chain reaction prim-
rs flanking each exon of the regions of interest were tdesigned to generate amplicons ranging in size from 200
o 600 bp, avoiding any nonunique sequences, as well as
ositions of known polymorphisms and mutations. The
roducts of all multiplex reactions for a specific patient were
ooled. Sequencing itself first required cluster generation,
hich is the process of attaching individual fragments from
patient’s library to a chambered glass slide and replicating
hem in situ to produce distinct islands of homogeneous
ragments. Using the Genome Analyzer II (Illumina, Inc.),
equencing-by-synthesis chemistry was performed in the
lide chambers to which the clusters were attached. Each
ase (A, C, G, or T) added to a growing DNA strand
iberates 1 of 4 associated fluorochromes in a local reaction
hat was captured by photoimaging cycle for each cluster.
hotoimaged data from each cluster of molecules were
onverted to base calls and aligned to a reference se-
uence for each gene of interest using Illumina-provided
oftware. Various annotation databases (e.g., dbSNP,
GMD, and the rapidly growing local compilations)
ere used, when possible, to classify nucleotide differences
nto various categories, ranging from polymorphisms to patho-
enic mutations.
lectrophysiology. The electrophysiologic properties of
utant KCNQ1 channels were obtained by overexpression
n Xenopus laevis oocytes as previously described (8,17,18).
xperiments were performed in cells expressing WT human
CNQ1 (NP_000209.2) and WT human KCNE1
NP_001121142). Mutations were generated by polymerase
hain reaction–based site direct mutagenesis of the WT
CNQ1 construct, using PFU ultra DNA polymerase and
onstruct sequences confirmed by DNA sequencing. The
verage measurement of at least 18 cells expressing mutant
hannels were used to determine changes in ion channel
arameters compared to WT channels. Thus, the same
CNQ1 source was used for all of the mutant ion channels,
ith the only difference being the mutation specified in the
tudy. All mutations analyzed for TRP were present among
tudy subjects.
In brief, WT and mutant KCNQ1 cRNA were injected
nto oocytes in a 1:1 ratio, together with the KCNE1
ubunit (0.5:0.5:1 ratio WTKCNQ1:MutKCNQ1:KCNE1).
he IKs tail current at –40 mV was measured after
epolarization to a series of voltage steps from –50 to 80
V every 10 mV, and a Boltzmann fit (G  gmax/(1 
exp[–(V – V1/2)/k) of these data was used to determine the
steepness or slope factor (k), the voltage that elicits half of
the maximal activation (V1/2) of activation, and the maximal
onductance (gmax). Nonsense mutation effects were as-
umed to have had a haploinsufficient phenotype, and effects
ere evaluated by measuring currents with decreased WT
xpression (0.5:1 ratio WTKCNQ1:KCNE1).
tatistics. Linear regression was used to test for correlation
etween simulated repolarization time using the model
escribed above and QTc measured from patients. Kaplan-
eier survival analysis was used to determine the cumula-ive probability of cardiac events by simulated repolarization
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In Silico Risk Assessment LQT November 20/27, 2012:2182–91times and by measured QTc interval, and significance was
tested by the log-rank test. Multivariate Cox proportional
hazards regression modeling was used to evaluate the
independent contribution of simulated repolarization times
to the occurrence of cardiac events from birth through age
40 years. Additional prespecified covariates in the multivar-
iate models included sex, the patient’s individual QTc, and
time-dependent beta-blocker therapy (i.e., by taking into
account in the multivariate model’s information regarding
administration of beta-blockers given to patients at different
time points during follow-up). Patients who did not have an
ECG for QTc measurement (n 92) were identified in the
Cox models as “QTc missing,” and all Cox models were
adjusted for this missing QTc parameter. Data from the
International LQTS Registry demonstrated that an age-
interaction existed regarding the effect of sex and genotype
on the occurrence of cardiac events, with a crossover effect
for both genotype and sex after the onset of adolescence
(5,19). During childhood, the risk for cardiac events is
significant higher in boys with LQTS, in particular
LQT1 (5,19 –21). Therefore, to avoid a violation of the
proportional-hazards assumption, models were carried out
using a time-dependent covariate for sex with prespecified
younger males (ages 0 through 13 years) and older females
(ages 14 through 40 years), allowing for different hazard
ratios by sex before and after adolescence.
Because almost all of the patients were first- and second-
degree relatives of probands, the effect of lack of indepen-
dence between patients was evaluated in the Cox model,
with grouped jackknife estimates for family membership (9).
All grouped jackknife standard errors for the covariate risk
factors fell within 3% of those obtained from the unadjusted
Cox model, and therefore only the Cox model findings are
reported. The statistical software used for the analyses was
SAS version 9.20 (SAS Institute Inc., Cary, North Caro-
lina). A 2-sided 0.05 significance level was used for hypoth-
esis testing.
Results
Simulation of transmural repolarization time. Simula-
tion of transmural ECGs was performed for each of the
mutants using mutant basic electrophysiological character-
istics as previously determined (8), producing the simulated
transmural electrical potentials shown in Figures 1A and
1B. The change in simulated transmural repolarization time
for mutant channels compared to WT is referred to as the
TRP. Transmural repolarization was defined as the differ-
ence of WT and mutant pseudo-transmural QT measured
at the end of the T wave. The maximal slope intercept
method was used, defining the end of the T wave as the
intercept between the isoelectric line with the tangent
drawn through the maximum down slope of the T wave
(Fig. 1C). TRP values associated with each mutant channel
are shown in Figures 1A and 1D. For one of the mutant
channels tested (D611Y), repolarization time was predicted mto be shorter (–7 ms) than the one produced by the presence
of the WT channel, while other mutations caused changes
ranging from 4 ms (R591H) to 49 ms (G314S). The
ean TRP for all mutations was 27.5 ms. Mutations with
he largest effects on TRP (top quartile [36 ms]) were
resent in the transmembrane domain of the channel—1 in
he S4-S5 cytoplasmic loop (V254M), 1 in the S5 mem-
rane spanning domain (L266P), and 2 in the pore loop
T312I and G314S). Figure 1E shows the KCNQ1 channel
rotein with the location of the mutations in the study
opulation. Mutations resulting in TRP in the top quartile
re shown in red, and others are shown in green.
aseline patient characteristics by TRP. A simulated
alue of prolonged transmural repolarization (TRP upper
uartile) among all mutations studied was present in 186
atients (29%). The mean QTc of these patients was 502 
3 ms, significantly prolonged compared to patients with a
imulated lower quartiles TRP (475  49 ms; p  0.001).
ther baseline characteristics of patients with upper quartile
RP are shown in Table 1, demonstrating no significant
ifference in heart rate (RR interval), sex, or beta-blocker
sage among patients with a prolonged TRP. In addition,
atients with upper quartile TRP had a higher frequency of
ardiac events during follow-up, including syncope, ACA,
nd SCD (Table 1).
orrelation between TRP and measured QTc. To mea-
ure the correlation between TRP and individual patient
Tc, TRP for each patient was plotted against the patients’
Characteristics of the Study PopulationTable 1 Characteristics of the Study Population
Characteristic
TRP
p Value
Upper Quartile
(n  186)
Lower Quartiles
(n  447)
ECG parameters
Overall QTc, ms 502 53 475 49 0.001
QTc 500 ms 49 26 0.001
RR, ms 804 232 847 200 0.04
LQTS therapies during follow-up
Beta blockers 47 44 0.49
Pacemaker 1.1 2.2 0.49
ICD 6 8 0.39
Cardiac events during follow-up
Syncope 59 29 0.001
ACA, % 7 2 0.007
SCD 18 7 0.001
Appropriate ICD shocks 0 0.2
ACA or SCD* 23 9 0.001
Race
Caucasian 69.5 80 0.001
Asian 2 12 0.001
Other 0.5 0
Unknown† 28 8 0.001
Values are mean  SD or %. *Only the first event for each patient was considered. †Patients of
unknown race from Northern European Registries, likely Caucasian.
ACA  aborted cardiac arrest; ICD  implantable cardioverter defibrillator; LCSD  left cervical
sympathetic denervation; MS  membrane spanning domain; SCD  sudden cardiac death.easured baseline QTc (Fig. 1D). This plot illustrates the
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November 20/27, 2012:2182–91 In Silico Risk Assessment LQTbroad variation in QTc measurements from patients with the
same mutation. Simple linear regression (shown as red solid
line), demonstrates a weak association between QTc and TRP
(R  0.27; p  0.0001). Although the values were correlated,
here was a wide distribution of individual QTcs for each
odeled mutation. The baseline QTc measurements varia-
ion among patients with the same IKs mutation also was
onsistent with the significant variation observed among
ultiple measurements taken from a single individual (7).
The correlation coefficient (R2) for a linear correlation
etween individual QTc for all patients and mean QTc for
atients with each mutation was 0.11 (Online Fig. 4A),
uggesting that QTc variability among individuals shows, as
RP, a weak correlation with QTc variability. These results
uggest that modeled TRP values predicted the ion channel
utation–specific contribution of cardiac risk. Consistent
ith TRP explaining a population variability of QTc, TRP
howed a reasonable correlation with the mean QTc in a
opulation with the same mutation (TRP vs. mean QTc for
ll patients with each mutation; R2  0.35) (Online Fig. 4B).
n addition, to estimate individual QTc variability, data
rom 10 patients in whom a large number of QTc determi-
ations was available were examined (these data were not
ncluded in the primary study). These patients showed an
verage QTc standard deviation of (39  1 ms) (Online
Fig. 5), similar to that found among patients with the same
mutation (39  2 ms) (Online Fig. 5), suggesting that QTc
variability may reflect, in large, variability observed in the
individual patient over time. Because of this inherent
variability in QTc determination, deterministic modeling
results, such as TRP, may provide a clearer signal that can
be used to evaluate risk in the patient.
TRP is an independent risk factor for cardiac events in
LQT1. In a multivariate Cox regression model, mutant-
specific TRP was significantly associated with an increased
rate of cardiac events both as a continuous and as a
dichotomized variable independent from other clinical vari-
ables and after adjustment for the patient’s individual QTc
(Table 2). For every additional 10-ms increment in simu-
lated TRP, there was a corresponding significant 35% (p 
0.001) increase risk for the occurrence of cardiac events.
Kaplan-Meier survival analysis with 4 subclassifications of
TRP showed that the top quartile of TRP has an increased
cumulative probability of cardiac events compared to those
of the 3 lower quartiles (Online Fig. 6), indicating that
probability of cardiac events is associated with a threshold
level of TRP. In patients with mutations identified to have
upper quartile with a simulated TRP, the risk for cardiac
events was increased nearly 3-fold (p  0.001). Consistent
ith these findings, Kaplan-Meier survival analysis
Fig. 2A, middle panel) showed that the cumulative prob-
bility of cardiac events from birth through age 40 years was
ignificantly higher among patients with upper quartile
imulated TRP compared with patients with lower TRP
alues. The population in the International Long QT
egistry is estimated to be approximately 90% Caucasian.sian race is underrepresented in the high quartile TRP
Table 1); nonetheless, when race was included in the
odels, it did not predict outcome, and the effect of TRP
as similar.
imulation of transmural ECG prolongation as an
ndependent risk factor for cardiac events in LQT1 in
atient with QTc <500 ms. In a secondary analysis, risk
factors for cardiac events were evaluated among patients
with only mild to moderate QTc prolongation (500 ms)
because, in this patient subset, individual QTc provides less
prognostic information. Among these patients, each addi-
tional 10 ms of simulated TRP was associated with a
significant 36% (p 0.001) increased risk for cardiac events
(Table 3). Upper quartile TRP was associated with nearly a
3-fold increased risk (2.97; 95% CI: 2.00 to 4.40) after
adjustment for patients’ individual QTc. Consistent with
these findings, Kaplan-Meier curves including only patients
with QTc 500 ms demonstrated early separation of
event-free survival rates when patients were grouped into
the upper versus lower TRP quartiles (Fig. 2B). When
patients were stratified by both individual baseline QTc and
TRP, Kaplan-Meier survival analysis showed that the group
with upper TRP had a significantly higher event rate
throughout follow-up, regardless of patients’ individual
QTc (Fig. 2C). Results from multivariate Cox proportional
hazard regression analysis corresponding to the groups in
Figure 2C are shown in Online Table 2.
To test whether TRP simulation parameters further
improved clinical risk stratification compared with previ-
ously identified risk factors related to ion channel charac-
teristics, secondary analysis added slow rate of channel
activation as a covariate. Previous work showed that that
channels with slow rates of activation (over 20% slower than
WT channels) were associated with an increased risk for
Multivariate Analysis: Risk Factors for CardiacEvents (Syncope, Sudden De th, and Abo tedCard ac Arrest) Among Pati n s With LQT1*
Table 2
Multivariat Analy is: Risk Factors for Cardiac
Events (Syncope, Sudden Death, and Aborted
Cardiac Arrest) Among Patients With LQT1*
Parameter Hazard Ratio 95% CI p Value
TRP assessed as a continuous
measure
TRP per 10 ms 1.35 1.18–1.56 0.001
QTc 500 ms vs. 500 ms 1.78 1.34–2.38 0.001
Male age 13 years 1.58 1.16–2.14 0.003
Female age 14 years 1.47 0.98–2.19 0.06
Time-dependent -blocker 0.37 0.20–0.66 0.001
TRP dichotomized at the
upper quartile
TRP Q4 vs. Q1–3 2.80 1.96–4.01 0.001
QTc 500 ms vs. 500 ms 1.78 1.37–2.32 0.001
Male age 13 years 1.60 1.19–2.15 0.002
Female age 14 years 1.38 0.91–2.09 0.13
Time dependent -blocker 0.32 0.18–0.58 0.001
*Multivariate analysis was carried out using Cox proportional hazards regression modeling; separate
models were developed for each analysis, with adjustments for the 5 covariates in each part.
LQT1  long QT syndrome type 1; QTc  QT interval corrected for heart rate; TRP  simulated
seudo-transmural electrocardiographic prolongation.cardiac events (8). The results showed that for both the
2188 Hoefen et al. JACC Vol. 60, No. 21, 2012
In Silico Risk Assessment LQT November 20/27, 2012:2182–91population as a whole and for patients with QTc 500 ms,
slower channel activation and TRP top quartile were inde-
pendent risk factors (Table 3). Additionally, because QTc
480 ms was found to be a very poor predictor of event risk
Figure 2 Rate of Cardiac Event During Follow-Up
Cumulative probability of the first cardiac event (syncope, aborted cardiac
arrest, or death) during follow-up, dichotomized by patients with the highest
quartile TRP (Q4) and all other quartiles (Q1–3) (A) among all study patients;
(B) among the subset of patients with QTc 500 ms; (C) among all patients
with combined assessment of TRP and QTc. Abbreviations as in Figure 1.in this population (hazard ratio [HR]: 0.96; 95% CI: 0.63 to1.46; p  0.85), a secondary analysis evaluated the association
between QTc450 ms and event risk in this population. This
lower threshold was a similarly poor predictor of risk (HR:
1.09; 95% CI: 0.71 to 1.67; p  0.71) (Online Table 3).
Simulation of transmural ECG prolongation as an inde-
pendent risk factor for life-threatening cardiac events
(ACA/SCD) in LQT1. In a multivariate Cox regression
model, mutation-specific TRP was also significantly asso-
ciated with an increased risk for live-threatening cardiac
events (defined as first occurrence of ACA or SCD). The
risk for ACA/SCD associated with TRP was consistent
when this parameter was assessed as both a continuous
measure and dichotomized at the upper quartile (36 ms),
after adjustment for individual patients’ QTc (Table 4).
Thus, for every additional 10 ms of added simulated
transmural repolarization time, there was a corresponding
significant 37% increase in the risk for ACA/SCD. Fur-
thermore, the group carrying a mutation with upper quartile
TRP had a 2-fold (p  0.002) increased risk for ACA/
SCD after adjustment for the individual patients’ QTc
(Table 5). This is also illustrated by Kaplan-Meier curves
(Fig. 3), with early separation of event-free survival rates for
the population of patients with upper quartile TRP.
Discussion
This study describes a method of simulating transmural
myocardial repolarization based on WT and mutant channel
characteristics determined in cellular electrophysiology.
This transmural repolarization parameter was found to be
an independent predictor for the occurrence of cardiac
events and life-threatening events in patients with LQT1.
The risk associated with simulated TRP was shown to be
independent of patients’ baseline QTc. These results re-
garding mutation-specific risk are particularly important for
the subpopulation with mild to moderate QTc prolongation
Multivariate Analysis: Risk Factors for CardiacEvents (Syncope, Sudden De th and AbortedCard ac Arrest) Among 369 patients with LQT1 andQTc <500 ms
Table 3
Multivariate Analysis: Risk Factors for Cardiac
Events (Syncope, Sudden Death and Aborted
Cardiac Arrest) Among 369 patients with LQT1 and
QTc <500 ms
Parameter Hazard Ratio 95% CI p Value
TRP assessed as a continuous
measure
TRP per 10 ms 1.36 1.18–1.56 0.001
QTc 480 ms vs. 480 ms 0.99 0.67–1.46 0.97
Male aged 13 years 1.42 0.87–2.33 0.16
Female aged 14 years 1.86 0.96–3.60 0.06
Time-dependent -blocker 0.48 0.23–1.02 0.06
TRP dichotomized at the
upper quartile
TRP Q4 vs. Q1–3 2.97 2.00–4.40 0.001
QTc 480 ms vs. 480 ms 0.96 0.63–1.46 0.85
Male aged 13 years 1.38 0.86–2.21 0.19
Female aged 14 years 1.90 0.98–3.67 0.06
Time dependent -blocker 0.45 0.22–0.58 0.04Abbreviations as in Table 2.
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prognostic value. This report shows cardiac modeling being
used as an arrhythmic risk predictor validated against a
patient population in clinical practice.
Several experimental and computation models have been
developed on the premise that transmural ECGs are a
surrogate for the QT interval as measured by body surface
ECGs. Transmural repolarizations are also thought to be
particularly important in generating inhomogeneities of
repolarization that lead to cardiac arrhythmias (22,23). IKs
channel expression changes across the ventricular wall, contrib-
uting to transmural dispersion of repolarization (24–26). This
is consistent with the present results, which indicate a
significant increase in cardiac risk associated with mutation-
Multivariate Analysis: Risk Factorsfor Cardi c Events (Syncope, Sudden Deathand Aborted Cardiac Arrest)*
Table 4
Mul ivariate Analysis: Risk Factors
for Cardiac Events (Syncope, Sudden Death
and Aborted Cardiac Arrest)*
Parameter Hazard Ratio 95% CI p Value
TRP dichotomized at the upper
quartile for the whole
population
TRP Q4 vs. Q1–3 2.25 1.49–3.39 0.001
act 1.20 1.42 1.00–2.03 0.05
QTc 500 ms vs. 500 ms 1.73 1.32–2.27 0.001
Male aged 13 years 1.60 1.17–2.18 0.003
Female aged 14 years 1.39 0.981–2.11 0.12
Time dependent -blocker 0.33 0.18–0.59 0.001
TRP dichotomized at the upper
quartile for patients with
QTc 500 ms
TRP Q4 vs. Q1–3 2.11 1.23–3.61 0.01
act 1.20 1.70 1.03–2.80 0.04
QTc 480 ms vs. 480 ms 0.94 0.62–1.43 0.78
Male aged 13 years 1.39 0.84–2.28 0.19
Female aged 14 years 1.86 0.95–3.65 0.07
Time dependent -blocker 0.44 0.21–0.92 0.03
*Multivariate analysis was carried out using Cox proportional hazards regression modeling; separate
models were developed for each analysis, with adjustments for the covariates in each part.
Abbreviations as in Table 2.
Multivariate Analysis: Risk Factors forSCD/ACA Among All Patients With LQT1*Table 5 Multivariate A alysis: Risk Factors forSCD/ACA Among All Patients With LQT1*
Parameter Hazard Ratio 95% CI p Value
TRP used as a continuous variable
TRP per 10-ms increment 1.27 1.02–1.59 0.03
QTc 500 ms 3.93 1.96–7.87 0.001
Male age 13 years 2.16 1.22–3.84 0.008
Female age 14 years 1.19 0.63–2.26 0.59
Time dependent -blocker 0.40 0.16–0.98 0.046
TRP dichotomized at top quartile
TRP Q4 vs. Q1–3 2.24 1.96–4.01 0.002
QTc 500 ms vs. 500 ms 3.95 1.37–2.32 0.001
Male age 13 years 2.24 1.19–2.15 0.005
Female age 14 years 1.12 0.91–2.09 0.74
Time dependent -blocker 0.38 0.15–0.94 0.04
*Multivariate analysis was carried out using Cox proportional hazards regression modeling;d
separate models were developed for each analysis, adjusting for the 5 covariates in each part.
Abbreviations as in Table 2.specific changes in IKs and transmural repolarization in
LQT1. In these models, the action potential duration
dispersion can produce conditions to support reentrant
activation patterns. Future, more detailed studies of ar-
rhythmia mechanisms modeling higher dimensional tissue
structure that can support a reentrant activation pattern are
necessary. In addition, the use of TRP as an index for
cardiac risk in other inherited and acquired LQT syndromes
is promising but needs further study.
The authors showed previously that a slow activation rate
is an independent risk factor in LQT1. The results indicate
that TRP is independent from channel slow activation rate.
Notable is that all 4 mutant channels in the top quartile of
TRP show also slow activation kinetics (8). Nonetheless,
TRP combines slower activation, changes in voltage depen-
dence of activation, and conductance of the channel in
relevant cardiac cell types to provide an overall effect of the
mutation regarding transmural repolarization. This utilizes
information on ion channel distribution and consequences
of ion channel dysfunction for APD and propagation across
the myocardial wall. Using this novel method, 4 high-risk
mutations were identified, only 1 of which had been
identified in the previous study. Most important, the pres-
ent study showed that these high-risk mutations predicted
life-threatening arrhythmic risk in the study population.
The simulation model proposed here consists of electri-
cally coupled cardiac cells with heterogeneous electrophysi-
ologic properties that produce waveforms that are similar to
those measured experimentally (27–29). The development
of heterogeneous models depends both on accurately rep-
resenting the AP of the different cell populations and
realistic coupling between the cells. At the single cell level,
the exact difference in membrane currents and Ca2 han-
Figure 3 Rates of Life-Threatening
Cardiac Events During Follow-Up
Cumulative probability of aborted cardiac arrest or sudden cardiac death during
follow-up among all study patients, dichotomized by patients with the highest
quartile TRP (Q4) and all other quartiles (Q1–3). Abbreviations as in Figure 1.ling that produce differences across the ventricular wall is
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dent. On the basis of the 3 standard cell types (epi-, endo-,
and midmyocardial) in Flaim et al. (14), parameters were
continually varied to interpolate differences in IKs, transient
outward potassium current (Ito), INaL, and Ca
2 handling in
n attempt to match the experimentally measured transmu-
al profiles (28). The conductivity between cells was as-
umed to have been fixed, so that the conduction velocity
as constant across the ventricular wall, as seen experimen-
ally (28,30). This assumption of constant conductivity is
onsistent with the limited available experimental data that
how that resistance is uniform, with the exception of a layer
ith higher resistivity (29). This layer, situated to roughly
0% depth, involves a systematic change in cellular orien-
ation. The discontinuity in cellular orientation cannot be
irectly represented in the 192 equally spaced point models
omprising our 1-D cable. However, future extensions to
he model could incorporate this additional level of detail.
A recent study (31) used Markov models, AP and
ransmural ECG simulations to infer the mechanism of
rrhythmia generation associated with a LQT1 associated
utation present in 1 patient with normal QTc and a
istory of syncope (Q357R, not included in the present
tudy). The predisposition to arrhythmia was demonstrated
y the propensity to generate early after depolarization
EADs) when combined with IKr blockage and beta-
drenergic drive, whereas the effect on the simulated TRP
lone (without IKr blockage and beta-adrenergic drive) was
ild (13 ms). This TRP value is comparable to the ones
ssociated with mutations in this study with TRP in the first
uartile, a range associated with 35% risk for a cardiac event
y age 40 years. In contrast to the previous study, the
resent study focuses on how TRP relates to a clinical risk
hat may be revealed over the time frame of up to 40 years
or a patient population. Because the present study included
large number of mutations, we chose a simpler Hodgkin-
uxley model of IKs that could be systematically con-
trained by the in vitro data. Although Markov models can
otentially capture additional mechanistic details of ion
hannel function, identification of states and constraining
arameters are difficult and complex with typical electro-
hysiologic data (32).
Simulated repolarization prolongation weakly correlated
ith baseline QTc measurements in the study population,
hich supports physiologic relevance of the simulation
ethod. However, QTc measurements can vary widely
mong patients with a particular mutation and over time in
he same patient (7). In addition, QTc has been shown to
hange during exercise (33) and with age (5) and has been
uggested to depend on a patient’s emotional state (34). The
imulated transmural repolarization parameter described
ere may reflect an overall lifetime risk in patients with each
pecific mutation, a risk that may not be reflected in a single
etermination of patients’ QTc. A reasonable correlation
as found between the TRP and the mean QTc in a
opulation with the same genotype, suggesting that deter- tinistic modeling results may provide a clearer signal than
atient data with high variability and stochastic effects.
ther genetic factors (e.g., SNPs in ion channels, modifier
rotein, and receptors) and unknown functional effect of the
utations, such as a decrease in beta-adrenergic activation
35), that are not taken into account in the TRP modeling,
ay also influence individual patients’ QTc and/or risk for
ardiac arrhythmias, with the possibility of both influencing
r masking genotype-specific cardiac risk.
Here, mutations associated with high risk for cardiac
vents were identified in patients with LQT1. Four of these
utations, the ones included in the top quartile of repolar-
zation dysfunction, were identified as being of particularly
igh risk: V254M, L266P, T312I, and G314S. These are all
ighly conserved residues among voltage-gated potassium
hannels, suggesting an important physiologic role (8,36).
he authors recently showed that V254M has impaired
eta-adrenergic activation, which would contribute to an
ncrease in risk in patients with this mutation at high
drenergic states; the other mutations were not identified
reviously as being of particularly high risk.
tudy limitations. Although the present findings regard-
ng the use of simulated TRP in risk stratification are novel,
hese results are based on a single-population study of 633
atients with LQT1, and therefore need to be further
alidated in larger populations, comprising also patients
ith recently identified novel mutations in the KCNQ1
ene. Partly retrospective data collection has limitations.
owever, because this is an analysis of registry data of a rare
isease (in which a prospective clinical trial or an analysis of
vents from birth would be difficult), the authors believe
hat this type of analysis is the best way to handle the
urvival bias conferred by entering the registry at an older
ge and the exclusion of higher-risk patients who died at a
ounger age. The present study attempted to identify the
ncremental prognostic implications of computed modeling
f electrophysiologic modeling in LQTS, but did not
nvestigate the reason why the model TRP is a good risk
redictor. For this, higher-dimensional tissue structure that
an support a re-entrant activation pattern is necessary.
onclusions
he identification of mutations conferring a high risk for
ardiac events can help to guide treatment decisions by
dentifying those patients who will benefit most from
herapies including pharmacologic agents (i.e., beta-
lockers) and implantable defibrillators. In particular, pa-
ients with moderate QTc prolongation (i.e., QTc 500
s) are a challenge for clinicians because their risk for
ardiac events remains significantly elevated compared to
hat of the general population, although the markers of risk
re relatively unknown (9). We have shown that simulated
RP is a particularly strong marker of risk for cardiac events
n this population, which may translate into changes in
reatment decisions for identifying high-risk LQTS patients
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November 20/27, 2012:2182–91 In Silico Risk Assessment LQTindependently of traditional ECG markers. It would be rec-
ommended that patients with the identified prolonged TRP
mutations (V254M, G314S, T312I, and L266P) should be
considered to be at a high risk for cardiac events even in the
absence of QTc prolongation or other clinical risk factors. This
patient subset should be routinely treated with beta-blocker
therapy at the maximal tolerated dosage and carefully followed
up for residual symptoms during medical therapy.
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APPENDIX
For a supplemental Methods section, tables, figures, and references, and
additional details on the in silico methods, please see the online version of
this article.
